Taro Provides Results for Quarter Ended June 30, 2020

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. ZETA
10. DAL

Go back to Taro Provides Results for Quarter Ended June 30, 2020

Taro Pharma (TARO) Reports Q1 Loss of $11.37 on Revenues of $117.6M

July 29, 2020 5:11 PM EDT

Taro Pharma (NYSE: TARO) reported Q1 EPS of ($11.37), versus $1.72 reported last year. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $158.35 million.

Quarter ended June 30, 2020 Highlights - compared to Quarter ended June 30, 2019

Net sales of $117.6 million, decreased $43.7 million.Gross profit of $64.9 million decreased $36.8 million, and as a percentage of net sales was 55.2% compared to 63.1%.Research and development expenses of $12.9 million decreased slightly from the prior year.Selling, marketing, general and administrative expenses of $22.2 million, which includes the impact of COVID-19 related... More